METASTATIC SQUAMOUS CELL CARCINOMA
Clinical trials for METASTATIC SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can a shorter chemo schedule work as well for head and neck cancer?
Disease control Recruiting nowThis study compares two ways of giving the chemotherapy drug 5-FU to people with head and neck cancer that has spread or come back after prior treatments. One group gets the drug over two days every two weeks, the other over four days every three weeks. The goal is to see which s…
Matched conditions: METASTATIC SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
New cocktail of cancer drugs targets Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis early-stage trial is testing a new three-drug combination for people with head and neck cancer that has come back or spread. The drugs include a targeted therapy (zanzalintinib), an immunotherapy (pembrolizumab), and another targeted antibody (cetuximab). The main goal is to…
Matched conditions: METASTATIC SQUAMOUS CELL CARCINOMA
Phase: PHASE1 • Sponsor: University of Chicago • Aim: Disease control
Last updated Jun 27, 2026 08:01 UTC